Sobi - Swedish Orphan Biovitrum AB (publ) company profile
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach.…
About Sobi - Swedish Orphan Biovitrum AB (publ)
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.
Mission and direction
Sobi is a global biopharmaceutical company focused on developing and delivering innovative treatments for people living with rare diseases. Drawing on its scientific heritage and international reach, the company advances specialty medicines and related services that help address high unmet medical needs and improve everyday life for patients worldwide.
Company values
- Patient-centricity
- Innovation
- Integrity
- Collaboration
- Scientific excellence
- Compliance